Application no. and date | 11758519.0 (espacenet) (Federated) (European Patent Register), 20110818 | Patent/reg. no. and date | DK/EP 2605757, 20150701 | Publication date | 20130626 | Priority no. and date | FR 1056689, 20100820 | EP pub. no. and date |
EP 2605757 20130626 | Effective date | | Applicant/owner | Debregeas Et Associes Pharma, 79 rue de Miromesnil
75008 Paris, FR | Applicant ref. no. | P016814EPDK1 EJ/GB | Inventor | SUPLIE, Pascal, 11 rue du 8 mai 1945
F-27400 Montaure, FR, LEBON, Christophe, 2 chemin de la Bénétrie
F-28260 Rouvres, FR, PAUL, David Olivier, 7 ruelle Bernage
F-28100 Dreux, FR | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/485 (2006.01) , A61K 47/02 (2006.01) , A61K 47/10 (2006.01) , A61K 47/26 (2006.01) , A61K 47/36 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/50 (2006.01) , A61P 25/04 (2006.01) | Title | Nalbuphinbaserede formuleringer og anvendelser deraf | Int. application no. | FR2011051929 | Int. publication no. | WO2012022919 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|